High Up-Front Costs Could Delay Access to Life-Saving Blood-Cancer Drugs for Medicare Patients
October 4, 2016
The significant out-of-pocket costs that cancer patients can face before Medicare drug benefits kick in may delay the patients’ treatment with a new class of highly effective therapies, according to a University of North Carolina study. In the study published … Read more